Exane Derivatives’s Lowe's Companies LOW Stock Holding History

Exane Derivatives’s Portfolio LOW Stock Details LOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$2.1K	Sell	12 -1,796	-99%	-$346K	﹤0.01%	433
2022 Q1	$366K	Buy	+1,808	New	+$416K	0.1%	224
2021 Q3	–	Sell	-488	Closed	-$94.8K	–	1062
2021 Q2	$94.8K	Buy	488 +19	+4%	+$3.72K	0.02%	541
2021 Q1	$89.2K	Buy	469 +462	+6,600%	+$79.3K	0.03%	436
2020 Q4	$1.12K	Hold	7	–	–	﹤0.01%	668
2020 Q3	$1.16K	Hold	7	–	–	﹤0.01%	606
2020 Q2	$946	Hold	7	–	–	﹤0.01%	554
2020 Q1	$602	Hold	7	–	–	﹤0.01%	575
2019 Q4	$836	Sell	7 -4	-36%	-$457	﹤0.01%	557
2019 Q3	$1.21K	Sell	11 -2,517	-100%	-$266K	﹤0.01%	527
2019 Q2	$255K	Sell	2,528 -27	-1%	-$2.85K	0.04%	236
2019 Q1	$280K	Sell	2,555 -802	-24%	-$80K	0.06%	190
2018 Q4	$310K	Buy	3,357 +7	+0.2%	+$675	0.06%	209
2018 Q3	$387K	Buy	3,350 +2,590	+341%	+$270K	0.07%	180
2018 Q2	$73.3K	Buy	760 +481	+172%	+$43.5K	0.01%	361
2018 Q1	$23.8K	Buy	279 +183	+191%	+$17.3K	﹤0.01%	390
2017 Q4	$8.92K	Sell	96 -5,059	-98%	-$418K	﹤0.01%	409
2017 Q3	$412K	Buy	5,155 +1,575	+44%	+$121K	0.08%	147
2017 Q2	$278K	Buy	3,580 +586	+20%	+$47.9K	0.06%	185
2017 Q1	$246K	Buy	2,994 +1,052	+54%	+$80.5K	0.06%	181
2016 Q4	$138K	Buy	+1,942	New	+$137K	0.03%	224
2016 Q3	–	Sell	-151,093	Closed	-$12M	–	645
2016 Q2	$12M	Sell	151,093 -44,724	-23%	-$3.46M	1.98%	17
2016 Q1	$14.8M	Sell	195,817 -35,734	-15%	-$2.52M	1.97%	6
2015 Q4	$17.6M	Sell	231,551 -33,220	-13%	-$2.47M	2.41%	12
2015 Q3	$18.2M	Buy	+264,771	New	+$18.2M	2.31%	15
2015 Q2	–	Sell	-296,047	Closed	-$22M	–	540
2015 Q1	$22M	Buy	296,047 +97,643	+49%	+$7M	2.43%	12
2014 Q4	$13.6M	Buy	+198,404	New	+$11.9M	1.89%	7

Other funds holding LOW

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PSCM

Pershing Square Capital Management New York $13.7B AUM 13.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Exane Derivatives's LOW Position: Q2 2022 in Review

Exane Derivatives reduced its Lowe's Companies (LOW) stake by 99% in Q2 2022, selling an estimated $346K and leaving 12 shares worth $2.1K. The position accounts for ﹤0.01% of the portfolio, ranked #433.

Exane Derivatives first reported a position in LOW in Q4 2014 and has held it in 27 quarters since. The position peaked at $22M in Q1 2015. 2,168 funds tracked by Wall St. Rank hold LOW as of Q2 2022.

Exane Derivatives held 12 shares of Lowe's Companies worth $2.1K as of Q2 2022.
Exane Derivatives sold 1,796 Lowe's Companies shares in Q2 2022, an estimated $346K.
Lowe's Companies made up ﹤0.01% of Exane Derivatives's portfolio in Q2 2022, its #433 holding.
Exane Derivatives first reported a position in Lowe's Companies in Q4 2014 and has held it in 27 quarters since.
Exane Derivatives's Lowe's Companies position peaked at $22M in Q1 2015.
2,168 funds tracked by Wall St. Rank held Lowe's Companies as of Q2 2022.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.